1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
2
|
Younes R and Bugianesi E: Should we
undertake surveillance for HCC in patients with NAFLD? J Hepatol.
68:326–334. 2018.PubMed/NCBI View Article : Google Scholar
|
3
|
Sartorius K, Makarova J, Sartorius B, An
P, Winkler C, Chuturgoon A and Kramvis A: The regulatory role of
MicroRNA in hepatitis-B virus-associated hepatocellular carcinoma
(HBV-HCC) pathogenesis. Cells. 8(1504)2019.PubMed/NCBI View Article : Google Scholar
|
4
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273.e1. 2012.PubMed/NCBI View Article : Google Scholar
|
5
|
Sagnelli C, Macera M, Pisaturo M, Zampino
R, Coppola M and Sagnelli E: Occult HBV infection in the
oncohematological setting. Infection. 44:575–582. 2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Ringelhan M, O'Connor T, Protzer U and
Heikenwalder M: The direct and indirect roles of HBV in liver
cancer: Prospective markers for HCC screening and potential
therapeutic targets. J Pathol. 235:355–367. 2015.PubMed/NCBI View Article : Google Scholar
|
7
|
Szpakowski JL and Tucker LY: Causes of
death in patients with hepatitis B: A natural history cohort study
in the United States. Hepatology. 58:21–30. 2013.PubMed/NCBI View Article : Google Scholar
|
8
|
Choi YM, Lee SY and Kim BJ: Naturally
occurring hepatitis B virus mutations leading to endoplasmic
reticulum stress and their contribution to the progression of
hepatocellular carcinoma. Int J Mol Sci. 20(597)2019.PubMed/NCBI View Article : Google Scholar
|
9
|
Kim CM, Koike K, Saito I, Miyamura T and
Jay G: HBx gene of hepatitis B virus induces liver cancer in
transgenic mice. Nature. 351:317–320. 1991.PubMed/NCBI View
Article : Google Scholar
|
10
|
Sadri Nahand J, Bokharaei-Salim F,
Karimzadeh M, Moghoofei M, Karampoor S, Mirzaei HR, Tabibzadeh A,
Jafari A, Ghaderi A, Asemi Z, et al: MicroRNAs and exosomes: Key
players in HIV pathogenesis. HIV Med. 21:246–278. 2020.PubMed/NCBI View Article : Google Scholar
|
11
|
Petrini E, Caviglia GP, Abate ML, Fagoonee
S, Smedile A and Pellicano R: MicroRNAs in HBV-related
hepatocellular carcinoma: Functions and potential clinical
applications. Panminerva Med. 57:201–209. 2015.PubMed/NCBI
|
12
|
Pu C, Wang J, Wei Q and Han P: Commentary
on ‘Asymptomatic prostatic inflammation in men with clinical BPH
and erectile dysfunction affects the positive predictive value of
prostate-specific antigen’. Agnihotri S, Mittal RD, Kapoor R,
Mandhani A, Department of Urology & Renal Transplantation,
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow,
India: Urol Oncol 2014; [Epub ahead of print]. doi:
10.1016/j.urolonc.2014.03.004. Urol Oncol. 33:103–104.
2015.PubMed/NCBI View Article : Google Scholar
|
13
|
Kelly EJ and Russell SJ: MicroRNAs and the
regulation of vector tropism. Mol Ther. 17:409–416. 2009.PubMed/NCBI View Article : Google Scholar
|
14
|
Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY,
Zhang JF, Shen HB, Zhang CY and Zen K: Serum microRNA profiles
serve as novel biomarkers for HBV infection and diagnosis of
HBV-positive hepatocarcinoma. Cancer Res. 70:9798–9807.
2010.PubMed/NCBI View Article : Google Scholar
|
15
|
Bertoli G, Cava C and Castiglioni I:
MicroRNAs: New biomarkers for diagnosis, prognosis, therapy
prediction and therapeutic tools for breast cancer. Theranostics.
5:1122–1143. 2015.PubMed/NCBI View Article : Google Scholar
|
16
|
Ma X, Feng J, Lu M, Tang W, Han J, Luo X,
Zhao Q and Yang L: microRNA-501-5p promotes cell proliferation and
migration in gastric cancer by downregulating LPAR1. J Cell
Biochem. 121:1911–1922. 2020.PubMed/NCBI View Article : Google Scholar
|
17
|
Vautrot V, Chanteloup G, Elmallah M,
Cordonnier M, Aubin F, Garrido C and Gobbo J: Exosomal miRNA: Small
molecules, big impact in colorectal cancer. J Oncol.
2019(8585276)2019.PubMed/NCBI View Article : Google Scholar
|
18
|
Sur S, Steele R, Shi X and Ray RB:
miRNA-29b inhibits prostate tumor growth and induces apoptosis by
increasing bim expression. Cells. 8(1455)2019.PubMed/NCBI View Article : Google Scholar
|
19
|
Vienberg S, Geiger J, Madsen S and
Dalgaard LT: MicroRNAs in metabolism. Acta Physiol (Oxf).
219:346–361. 2017.PubMed/NCBI View Article : Google Scholar
|
20
|
Portal-Núñez S, Esbrit P, Alcaraz MJ and
Largo R: Oxidative stress, autophagy, epigenetic changes and
regulation by miRNAs as potential therapeutic targets in
osteoarthritis. Biochem Pharmacol. 108:1–10. 2016.PubMed/NCBI View Article : Google Scholar
|
21
|
Guo D, Liu J, Wang W, Hao F, Sun X, Wu X,
Bu P, Zhang Y, Liu Y, Liu F, et al: Alteration in abundance and
compartmentalization of inflammation-related miRNAs in plasma after
intracerebral hemorrhage. Stroke. 44:1739–1742. 2013.PubMed/NCBI View Article : Google Scholar
|
22
|
Ura S, Honda M, Yamashita T, Ueda T,
Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K and Kaneko
S: Differential microRNA expression between hepatitis B and
hepatitis C leading disease progression to hepatocellular
carcinoma. Hepatology. 49:1098–1112. 2009.PubMed/NCBI View Article : Google Scholar
|
23
|
Giray BG, Emekdas G, Tezcan S, Ulger M,
Serin MS, Sezgin O, Altintas E and Tiftik EN: Profiles of serum
microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for
HBV-positive hepatocellular carcinoma. Mol Biol Rep. 41:4513–4519.
2014.PubMed/NCBI View Article : Google Scholar
|
24
|
Ninomiya M, Kondo Y, Kimura O, Funayama R,
Nagashima T, Kogure T, Morosawa T, Tanaka Y, Nakayama K and
Shimosegawa T: The expression of miR-125b-5p is increased in the
serum of patients with chronic hepatitis B infection and inhibits
the detection of hepatitis B virus surface antigen. J Viral Hepat.
23:330–339. 2016.PubMed/NCBI View Article : Google Scholar
|
25
|
Xu J, An P, Winkler CA and Yu Y:
Dysregulated microRNAs in hepatitis B virus-related hepatocellular
carcinoma: Potential as biomarkers and therapeutic targets. Front
Oncol. 10(1271)2020.PubMed/NCBI View Article : Google Scholar
|
26
|
Morishita A, Fujita K, Iwama H, Chiyo T,
Fujihara S, Oura K, Tadokoro T, Mimura S, Nomura T, Tani J, et al:
Role of microRNA-210-3p in hepatitis B virus-related hepatocellular
carcinoma. Am J Physiol Gastrointest Liver Physiol. 318:G401–G409.
2020.PubMed/NCBI View Article : Google Scholar
|
27
|
Meng FL, Wang W and Jia WD: Diagnostic and
prognostic significance of serum miR-24-3p in HBV-related
hepatocellular carcinoma. Med Oncol. 31(177)2014.PubMed/NCBI View Article : Google Scholar
|
28
|
Xie KL, Zhang YG, Liu J, Zeng Y and Wu H:
MicroRNAs associated with HBV infection and HBV-related HCC.
Theranostics. 4:1176–1192. 2014.PubMed/NCBI View Article : Google Scholar
|
29
|
Wang C, Su K, Lin H, Cen B, Zheng S and Xu
X: Identification and verification of a novel
MAGI2-AS3/miRNA-374-5p/FOXO1 network associated with HBV-related
HCC. Cells. 11(3466)2022.PubMed/NCBI View Article : Google Scholar
|
30
|
Ranjpour M, Katare DP, Wajid S and Jain
SK: HCC specific protein network involving interactions of EGFR
with A-Raf and transthyretin: experimental analysis and
computational biology correlates. Anticancer Agents Med Chem.
18:1163–1176. 2018.PubMed/NCBI View Article : Google Scholar
|
31
|
Liu H, Lei C, He Q, Pan Z, Xiao D and Tao
Y: Nuclear functions of mammalian MicroRNAs in gene regulation,
immunity and cancer. Mol Cancer. 17(64)2018.PubMed/NCBI View Article : Google Scholar
|
32
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009.PubMed/NCBI View Article : Google Scholar
|
33
|
Huang V and Li LC: miRNA goes nuclear. RNA
Biol. 9:269–273. 2012.PubMed/NCBI View Article : Google Scholar
|
34
|
Chen C, Chen H, Zhang Y, Thomas HR, Frank
MH, He Y and Xia R: TBtools: An integrative toolkit developed for
interactive analyses of big biological data. Mol Plant.
13:1194–1202. 2020.PubMed/NCBI View Article : Google Scholar
|
35
|
Fan Y, Siklenka K, Arora SK, Ribeiro P,
Kimmins S and Xia J: miRNet-dissecting miRNA-target interactions
and functional associations through network-based visual analysis.
Nucleic Acids Res. 44 (W1):W135–W141. 2016.PubMed/NCBI View Article : Google Scholar
|
36
|
Zhu HR, Yu XN, Zhang GC, Shi X,
Bilegsaikhan E, Guo HY, Liu LL, Cai Y, Song GQ, Liu TT, et al:
Comprehensive analysis of long non-coding RNA-messenger
RNA-microRNA co-expression network identifies cell cycle-related
lncRNA in hepatocellular carcinoma. Int J Mol Med. 44:1844–1854.
2019.PubMed/NCBI View Article : Google Scholar
|
37
|
Hensel KO, Cantner F, Bangert F, Wirth S
and Postberg J: Episomal HBV persistence within transcribed host
nuclear chromatin compartments involves HBx. Epigenetics Chromatin.
11(34)2018.PubMed/NCBI View Article : Google Scholar
|
38
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658.
2017.PubMed/NCBI View Article : Google Scholar
|
39
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu
JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis
of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110.
2017.PubMed/NCBI View Article : Google Scholar
|
40
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
41
|
Wang X, Hu H, Hu B, Xia H, Cheng X, Zheng
J, Zhang Z and Liu H: Dihydromyricetin inhibits Hepatitis B virus
replication by activating NF-κB, MAPKs, and autophagy in HepG2.2.15
cells. Mol Biol Rep. 50:1403–1414. 2023.PubMed/NCBI View Article : Google Scholar
|
42
|
Lou W, Liu J, Ding B, Chen D, Xu L, Ding
J, Jiang D, Zhou L, Zheng S and Fan W: Identification of potential
miRNA-mRNA regulatory network contributing to pathogenesis of
HBV-related HCC. J Transl Med. 17(7)2019.PubMed/NCBI View Article : Google Scholar
|
43
|
Ren M, Qin D, Li K, Qu J, Wang L, Wang Z,
Huang A and Tang H: Correlation between hepatitis B virus protein
and microRNA processor Drosha in cells expressing HBV. Antiviral
Res. 94:225–231. 2012.PubMed/NCBI View Article : Google Scholar
|
44
|
Zhang M, Bai X, Zeng X, Liu J, Liu F and
Zhang Z: circRNA-miRNA-mRNA in breast cancer. Clin Chim Acta.
523:120–130. 2021.PubMed/NCBI View Article : Google Scholar
|
45
|
Ma J, Wang P, Huang L, Qiao J and Li J:
Bioinformatic analysis reveals an exosomal miRNA-mRNA network in
colorectal cancer. BMC Med Genomics. 14(60)2021.PubMed/NCBI View Article : Google Scholar
|
46
|
Guerrieri F, Belloni L, D'Andrea D,
Pediconi N, Le Pera L, Testoni B, Scisciani C, Floriot O, Zoulim F,
Tramontano A and Levrero M: Genome-wide identification of direct
HBx genomic targets. BMC Genomics. 18(184)2017.PubMed/NCBI View Article : Google Scholar
|
47
|
Su Q, Schröder CH, Hofmann WJ, Otto G,
Pichlmayr R and Bannasch P: Expression of hepatitis B virus X
protein in HBV-infected human livers and hepatocellular carcinomas.
Hepatology. 27:1109–1120. 1998.PubMed/NCBI View Article : Google Scholar
|
48
|
Liang XH, Stemler M, Will H, Braun R, Tang
ZY and Schröder CH: Low incidence and high titers of antibodies to
hepatitis B virus X-protein in sera of Chinese patients with
hepatocellular carcinoma. J Med Virol. 25:329–337. 1988.PubMed/NCBI View Article : Google Scholar
|
49
|
Levrero M and Zucman-Rossi J: Mechanisms
of HBV-induced hepatocellular carcinoma. J Hepatol. 64 (Suppl
1):S84–S101. 2016.PubMed/NCBI View Article : Google Scholar
|
50
|
Peng F, Xiao X, Jiang Y, Luo K, Tian Y,
Peng M, Zhang M, Xu Y and Gong G: HBx down-regulated Gld2 plays a
critical role in HBV-related dysregulation of miR-122. PLoS One.
9(e92998)2014.PubMed/NCBI View Article : Google Scholar
|
51
|
Zhou SJ, Deng YL, Liang HF, Jaoude JC and
Liu FY: Hepatitis B virus X protein promotes CREB-mediated
activation of miR-3188 and Notch signaling in hepatocellular
carcinoma. Cell Death Differ. 24:1577–1587. 2017.PubMed/NCBI View Article : Google Scholar
|
52
|
Michlewski G and Cáceres JF:
Post-transcriptional control of miRNA biogenesis. RNA. 25:1–16.
2019.PubMed/NCBI View Article : Google Scholar
|
53
|
Bernardo BC, Ooi JYY, Lin RCY and McMullen
JR: miRNA therapeutics: A new class of drugs with potential
therapeutic applications in the heart. Future Med Chem.
7:1771–1792. 2015.PubMed/NCBI View Article : Google Scholar
|
54
|
lyu Z, Mao Z, Wang H, Fang Y, Chen T, Wan
Q, Wang M, Wang N, Xiao J, Wei H, et al: MiR-181b targets Six2 and
inhibits the proliferation of metanephric mesenchymal cells in
vitro. Biochem Biophys Res Commun. 440:495–501. 2013.PubMed/NCBI View Article : Google Scholar
|
55
|
Schmiedel JM, Klemm SL, Zheng Y, Sahay A,
Blüthgen N, Marks DS and van Oudenaarden A: Gene expression.
MicroRNA control of protein expression noise. Science. 348:128–132.
2015.PubMed/NCBI View Article : Google Scholar
|
56
|
Xiao M, Li J, Li W, Wang Y, Wu F, Xi Y,
Zhang L, Ding C, Luo H, Li Y, et al: MicroRNAs activate gene
transcription epigenetically as an enhancer trigger. RNA Biol.
14:1326–1334. 2017.PubMed/NCBI View Article : Google Scholar
|
57
|
Suzuki HI, Young RA and Sharp PA:
Super-enhancer-mediated RNA processing revealed by integrative
MicroRNA network analysis. Cell. 168:1000–1014.e15. 2017.PubMed/NCBI View Article : Google Scholar
|
58
|
Li N, Miao Y, Shan Y, Liu B, Li Y, Zhao L
and Jia L: MiR-106b and miR-93 regulate cell progression by
suppression of PTEN via PI3K/Akt pathway in breast cancer. Cell
Death Dis. 8(e2796)2017.PubMed/NCBI View Article : Google Scholar
|
59
|
Liang C, Xu Y, Ge H, Xing B, Li G, Li G
and Wu J: miR-564 inhibits hepatocellular carcinoma cell
proliferation and invasion by targeting the GRB2-ERK1/2-AKT axis.
Oncotarget. 8:107543–107557. 2017.PubMed/NCBI View Article : Google Scholar
|
60
|
Vaughan TY, Verma S and Bunting KD:
Grb2-associated binding (Gab) proteins in hematopoietic and immune
cell biology. Am J Blood Res. 1:130–134. 2011.PubMed/NCBI
|
61
|
Li J, Lv M, Huang Q, Hu R, Zhong X, Sun X,
Feng W, Han Z, Ma M, Zhang W and Zhou X: FAT4 expression in
peripheral blood mononuclear cells is associated with prognosis and
immune cell infiltration in hepatocellular carcinoma. Sci Rep.
13(15735)2023.PubMed/NCBI View Article : Google Scholar
|
62
|
Dunn GP, Dunn IF and Curry WT: Focus on
TILs: Prognostic significance of tumor infiltrating lymphocytes in
human glioma. Cancer Immun. 7(12)2007.PubMed/NCBI
|
63
|
Azimi F, Scolyer RA, Rumcheva P, Moncrieff
M, Murali R, McCarthy SW, Saw RP and Thompson JF:
Tumor-infiltrating lymphocyte grade is an independent predictor of
sentinel lymph node status and survival in patients with cutaneous
melanoma. J Clin Oncol. 30:2678–2683. 2012.PubMed/NCBI View Article : Google Scholar
|
64
|
Zhang X and Zhang J, Gao F, Fan S, Dai L
and Zhang J: KPNA2-associated immune analyses highlight the
dysregulation and prognostic effects of GRB2, NRAS, and their
RNA-binding proteins in hepatocellular carcinoma. Front Genet.
11(593273)2020.PubMed/NCBI View Article : Google Scholar
|
65
|
Lee CC, Li IJ, Chen YC, Cheng JW, Wu HH,
Weng CH, Fang JT and Tian YC: Comparable ten-year outcome in
hemodialysis patients with hepatitis C virus and hepatitis B virus
coinfection and single hepatitis B virus infection. Blood Purif.
32:89–95. 2011.PubMed/NCBI View Article : Google Scholar
|
66
|
Tacke F: Targeting hepatic macrophages to
treat liver diseases. J Hepatol. 66:1300–1312. 2017.PubMed/NCBI View Article : Google Scholar
|
67
|
Maheshwari A: Innate immune memory in
macrophages. Newborn (Clarksville). 2:60–79. 2023.PubMed/NCBI View Article : Google Scholar
|
68
|
Kawasaki T, Ikegawa M, Yunoki K, Otani H,
Ori D, Ishii KJ, Kuroda E, Takamura S, Kitabatake M, Ito T, et al:
Alveolar macrophages instruct CD8+ T cell expansion by
antigen cross-presentation in lung. Cell Rep.
41(111828)2022.PubMed/NCBI View Article : Google Scholar
|
69
|
Dai H, Lan P, Zhao D, Abou-Daya K, Liu W,
Chen W, Friday AJ, Williams AL, Sun T, Chen J, et al: PIRs mediate
innate myeloid cell memory to nonself MHC molecules. Science.
368:1122–1127. 2020.PubMed/NCBI View Article : Google Scholar
|